Contracts are part of C$184 million agreement for more than 15 facilities announced in August 2025 TREVIGLIO, Italy & BURLINGTON, Ontario–(BUSINESS WIRE)–AnaergiaContracts are part of C$184 million agreement for more than 15 facilities announced in August 2025 TREVIGLIO, Italy & BURLINGTON, Ontario–(BUSINESS WIRE)–Anaergia

Anaergia S.r.l. starting activities for additional C$25 million in Contracts for Two Projects in Spain

Contracts are part of C$184 million agreement for more than 15 facilities announced in August 2025

TREVIGLIO, Italy & BURLINGTON, Ontario–(BUSINESS WIRE)–Anaergia Inc. (“Anaergia”, the “Company”, “us”, or “our”) (TSX:ANRG; OTCQX:ANRGF), through its subsidiary Anaergia S.r.l., has been awarded project contracts for Andujar and Arjona with D.B. Andalucia, a special purpose company developing projects in the renewable sector in Spain.

These contracts are part of a previously disclosed agreement, announced on August 19, 2025, under which Anaergia S.r.l. will deliver a comprehensive suite of services and deploy its innovative, proven technology to support the construction of new anaerobic digestion plants in Spain. These facilities represent the second and third projects under the broader agreement for more than 15 plants, with an aggregate value of approximately C$184 million.

Under the terms of the contracts, both facilities, which are designed to convert waste from olive oil production into renewable biomethane, are expected to be completed within 18 months. Anaergia anticipates generating combined revenue of approximately C$25 million from these two projects.

“Each of these new facilities will convert approximately 100,000 tonnes per year of olive pomace into biomethane, highlighting the vital role of Infinitum in the production of sustainable energy,” said Alfonso De Gonzalo, Chairman of D.B. Andalucia. “These projects reflect our ongoing commitment to promoting the widespread adoption of clean and sustainable fuels.”

“Anaergia is increasingly recognized as a leader in the global transition toward sustainable energy solutions,” said Assaf Onn, CEO of Anaergia. “Delivering these plants represents an important step as we leverage our industry-leading solutions to help advance a cleaner, greener future.”

About Anaergia

Anaergia is a pioneering technology company in the RNG sector, with over 300 patents dedicated to converting organic waste into sustainable solutions such as RNG, fertilizer, and water. It is committed to addressing a significant source of greenhouse gas (GHG) emissions through cost-effective processes. Our proprietary technologies, combined with our engineering expertise and vast experience in facility design, construction, and operation, position Anaergia as a leader in the RNG industry. With a proven track record of delivering hundreds of innovative projects over the past decade, we are well-equipped to tackle today’s critical resource recovery challenges through diverse project delivery methods. As one of the few companies worldwide offering an integrated portfolio of end-to-end solutions, we effectively combine solid waste processing, wastewater treatment, organics recovery, high-efficiency anaerobic digestion, and biomethane production. Additionally, we operate RNG facilities owned by us, by third parties, or through joint ventures. This comprehensive approach not only reduces environmental impact but also significantly lowers costs associated with waste and wastewater treatment while mitigating GHG emissions.

For further information please see: www.anaergia.com

Forward-Looking Statements

This news release contains forward-looking information within the meaning of applicable securities legislation, which reflects Anaergia’s current expectations regarding future events, including but not limited to, counterparty contractual performance, the capability of the Company’s technology and performance with respect to the project objectives. Forward-looking information is based on a number of assumptions, including, but not limited to counterparty contractual performance, the development, timing and funding of the facilities, the capability of the Company’s technology and performance with respect to the project objectives, the expected revenue from the agreement and the specific projects under the agreement, and the sufficient sourcing of food waste and power generation. The Company is subject to a number of risks and uncertainties, many of which are beyond the Company’s control. Such risks and uncertainties include, but are not limited to, the factors discussed under “Risk Factors” in the Company’s annual information form for the fiscal year ended December 31, 2024, and under “Risks and Uncertainties” in the Company’s most recent management’s discussion and analysis. Actual results could differ materially from those projected herein. Anaergia does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required under applicable securities laws. Additional information on these and other factors that could affect Anaergia’s operations or financial results are included in Anaergia’s reports on file with Canadian regulatory authorities.

Contacts

For media and/or investor relations please contact: IR@Anaergia.com

Market Opportunity
Chainbase Logo
Chainbase Price(C)
$0.07135
$0.07135$0.07135
-0.30%
USD
Chainbase (C) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Gold Hits $3,700 as Sprott’s Wong Says Dollar’s Store-of-Value Crown May Slip

Gold Hits $3,700 as Sprott’s Wong Says Dollar’s Store-of-Value Crown May Slip

The post Gold Hits $3,700 as Sprott’s Wong Says Dollar’s Store-of-Value Crown May Slip appeared on BitcoinEthereumNews.com. Gold is strutting its way into record territory, smashing through $3,700 an ounce Wednesday morning, as Sprott Asset Management strategist Paul Wong says the yellow metal may finally snatch the dollar’s most coveted role: store of value. Wong Warns: Fiscal Dominance Puts U.S. Dollar on Notice, Gold on Top Gold prices eased slightly to $3,678.9 […] Source: https://news.bitcoin.com/gold-hits-3700-as-sprotts-wong-says-dollars-store-of-value-crown-may-slip/
Share
BitcoinEthereumNews2025/09/18 00:33
YouTube Advertising Formats: A Complete Guide for Marketers

YouTube Advertising Formats: A Complete Guide for Marketers

In today’s fast-evolving digital landscape, YouTube has emerged as one of the most powerful platforms for marketers looking to engage audiences through video. With
Share
Techbullion2026/01/21 01:49
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11